Channelpedia

Kv1.1 Channel

701 automatically matched literature references

2

Voigt N et al. Atrial-Selective Potassium Channel Blockers.
Card Electrophysiol Clin, 2016 Jun , 8 (411-21).

8

Wang X et al. A single-point mutation enhances dual functionality of a scorpion toxin.
Comp. Biochem. Physiol. C Toxicol. Pharmacol., 2015 Sep 7 , 179 (72-78).

17

Tsantoulas C Emerging potassium channel targets for the treatment of pain.
Curr Opin Support Palliat Care, 2015 Jun , 9 (147-54).

20

Daly D et al. Porphyrin derivatives as potent and selective blockers of neuronal Kv1 channels.
Chem. Commun. (Camb.), 2015 Jan 21 , 51 (1066-9).

22

Chen J et al. Genesis of anxiety, depression, and ongoing abdominal discomfort in ulcerative colitis-like colon inflammation.
Am. J. Physiol. Regul. Integr. Comp. Physiol., 2015 Jan 1 , 308 (R18-27).

23

Kuwabara S et al. Acquired and genetic channelopathies: in vivo assessment of axonal excitability.
Exp. Neurol., 2015 Jan , 263 (368-71).

24

33

Serikawa T et al. Advances on genetic rat models of epilepsy.
Exp. Anim., 2015 , 64 (1-7).

37

Bartok A et al. Margatoxin is a non-selective inhibitor of human Kv1.3 K(+) channels.
Toxicon, 2014 Sep , 87 (6-16).

40

Carrisoza-Gaytán R et al. Differential expression of the Kv1 voltage-gated potassium channel family in the rat nephron.
J. Mol. Histol., 2014 Oct , 45 (583-97).

41

Moore BM et al. The Kv1.1 null mouse, a model of sudden unexpected death in epilepsy (SUDEP).
Epilepsia, 2014 Nov , 55 (1808-16).

43

Lassche S et al. A novel KCNA1 mutation causing episodic ataxia type I.
Muscle Nerve, 2014 Mar 18 , ().

44

Rodríguez-Ravelo R et al. A K⁺ channel blocking peptide from the Cuban scorpion Rhopalurus garridoi.
Peptides, 2014 Mar , 53 (42-7).

47

Teichert RW et al. Using constellation pharmacology to define comprehensively a somatosensory neuronal subclass.
Proc. Natl. Acad. Sci. U.S.A., 2014 Jan 27 , ().

52

53

54

Sheng J et al. Electrophysiology of human cardiac atrial and ventricular telocytes.
J. Cell. Mol. Med., 2014 Feb , 18 (355-62).

56

Bloom S et al. Heterogeneous calretinin expression in the avian cochlear nucleus angularis.
J. Assoc. Res. Otolaryngol., 2014 Aug , 15 (603-20).

67

Hao J et al. Kv1.1 channels act as mechanical brake in the senses of touch and pain.
Neuron, 2013 Mar 6 , 77 (899-914).

72

74

Tomlinson SE et al. Clinical, genetic, neurophysiological and functional study of new mutations in episodic ataxia type 1.
J. Neurol. Neurosurg. Psychiatr., 2013 Jan 24 , ().

82

Krestel H et al. Differences between RNA and DNA due to RNA editing in temporal lobe epilepsy.
Neurobiol. Dis., 2013 Aug , 56 (66-73).

86

Carlisle FA et al. Specific expression of Kcna10, Pxn and Odf2 in the organ of Corti.
Gene Expr. Patterns, 2012 May-Jun , 12 (172-9).

89

96

Jan LY et al. Voltage-gated potassium channels and the diversity of electrical signalling.
J. Physiol. (Lond.), 2012 Jun 1 , 590 (2591-9).

99

Robbins CA et al. Kv1.1 and Kv1.2: Similar channels, different seizure models.
Epilepsia, 2012 Jun , 53 Suppl 1 (134-41).

102

Hocking JC et al. Neural activity and branching of embryonic retinal ganglion cell dendrites.
Mech. Dev., 2012 Jul , 129 (125-35).

108

Dwyer J et al. Resonance in neocortical neurons and networks.
Eur. J. Neurosci., 2012 Dec , 36 (3698-708).

111

113

Baloh RW Episodic ataxias 1 and 2.
Handb Clin Neurol, 2012 , 103 (595-602).

116

Moreno C et al. Polyunsaturated Fatty acids modify the gating of kv channels.
Front Pharmacol, 2012 , 3 (163).

117

Leanza L et al. Induction of apoptosis in macrophages via Kv1.3 and Kv1.5 potassium channels.
Curr. Med. Chem., 2012 , 19 (5394-404).

118

119

Fisahn A et al. Acoustic startle hypersensitivity in Mceph mice and its effect on hippocampal excitability.
Eur. J. Neurosci., 2011 Oct , 34 (1121-30).

125

Camargos TS et al. The new kappa-KTx 2.5 from the scorpion Opisthacanthus cayaporum.
Peptides, 2011 Jul , 32 (1509-17).

131

Zhu S et al. Molecular diversity and functional evolution of scorpion potassium channel toxins.
Mol. Cell Proteomics, 2011 Feb , 10 (M110.002832).

132

133

Streit AK et al. A-to-I RNA Editing Modulates the Pharmacology of Neuronal Ion Channels and Receptors.
Biochemistry Mosc., 2011 Aug , 76 (890-9).

134

Northcott PA et al. Medulloblastoma comprises four distinct molecular variants.
J. Clin. Oncol., 2011 Apr 10 , 29 (1408-14).

136

Deng YY et al. Role of microglia in the process of inflammation in the hypoxic developing brain.
Front Biosci (Schol Ed), 2011 , 3 (884-900).

139

Zironi I et al. Molecular remodeling of potassium channels in fibroblasts from centenarians: a marker of longevity?
Mech. Ageing Dev., 2010 Nov-Dec , 131 (674-81).

140

Wagner CA New roles for renal potassium channels.
J. Nephrol., 2010 Jan-Feb , 23 (5-8).

142

Al-Sabi A et al. Arrangement of Kv1 alpha subunits dictates sensitivity to tetraethylammonium.
J. Gen. Physiol., 2010 Sep , 136 (273-82).

143

San-Cristobal P et al. Novel molecular pathways in renal Mg2+ transport: a guided tour along the nephron.
Curr. Opin. Nephrol. Hypertens., 2010 Sep , 19 (456-62).

145

Xie G et al. A new Kv1.2 channelopathy underlying cerebellar ataxia.
J. Biol. Chem., 2010 Oct 15 , 285 (32160-73).

146

Rajakulendran S et al. PAW31 Clinical and genetic spectrum of the episodic ataxias: the UK perspective.
J. Neurol. Neurosurg. Psychiatr., 2010 Nov , 81 (e32).

148

Rangaraju S et al. Potassium channel modulation by a toxin domain in matrix metalloprotease 23.
J. Biol. Chem., 2010 Mar 19 , 285 (9124-36).

152

Graves TD et al. Nongenetic factors influence severity of episodic ataxia type 1 in monozygotic twins.
Neurology, 2010 Jul 27 , 75 (367-72).

153

Usman H et al. Potassium channel regulator KCNRG regulates surface expression of Shaker-type potassium channels.
Biochem. Biophys. Res. Commun., 2010 Jan 15 , 391 (1301-5).

154

van der Wijst J et al. Functional analysis of the Kv1.1 N255D mutation associated with autosomal dominant hypomagnesemia.
J. Biol. Chem., 2010 Jan 1 , 285 (171-8).

156

158

Serratrice G et al. [Potassium channelopathies and Morvan's syndromes].
Bull. Acad. Natl. Med., 2010 Feb , 194 (391-406; discussion 406-7).

161

Gazula VR et al. Localization of Kv1.3 channels in presynaptic terminals of brainstem auditory neurons.
J. Comp. Neurol., 2010 Aug 15 , 518 (3205-20).

168

Baraban SC et al. Reduction of seizures by transplantation of cortical GABAergic interneuron precursors into Kv1.1 mutant mice.
Proc. Natl. Acad. Sci. U.S.A., 2009 Sep 8 , 106 (15472-7).

169

172

Fenoglio-Simeone K et al. Anticonvulsant effects of the selective melatonin receptor agonist ramelteon.
Epilepsy Behav, 2009 Sep , 16 (52-7).

174

Sankaranarayanan K et al. Fast inactivation in potassium channels: an interplay of cytoplasmic domains.
Biochem. Biophys. Res. Commun., 2009 Oct 23 , 388 (490-5).

175

177

178

Feinshreiber L et al. Syntaxin modulates Kv1.1 through dual action on channel surface expression and conductance.
Biochemistry, 2009 May 19 , 48 (4109-14).

179

Damak M et al. Late onset hereditary episodic ataxia.
J. Neurol. Neurosurg. Psychiatr., 2009 May , 80 (566-8).

180

Jen JC et al. Familial episodic ataxia: a model for migrainous vertigo.
Ann. N. Y. Acad. Sci., 2009 May , 1164 (252-6).

181

Nekrasova OV et al. Recombinant Kv channels at the membrane of Escherichia coli bind specifically agitoxin2.
J Neuroimmune Pharmacol, 2009 Mar , 4 (83-91).

183

Shao M et al. Adaptation of chicken vestibular nucleus neurons to unilateral vestibular ganglionectomy.
Neuroscience, 2009 Jul 21 , 161 (988-1007).

187

Takacs Z et al. A designer ligand specific for Kv1.3 channels from a scorpion neurotoxin-based library.
Proc. Natl. Acad. Sci. U.S.A., 2009 Dec 29 , 106 (22211-6).

188

194

196

Ellison DH The voltage-gated K+ channel subunit Kv1.1 links kidney and brain.
J. Clin. Invest., 2009 Apr , 119 (763-6).

199

Kapur J Is epilepsy a disease of synaptic transmission?
, 2008 Sep-Oct , 8 (139-41).

201

203

Abbas N et al. A new Kaliotoxin selective towards Kv1.3 and Kv1.2 but not Kv1.1 channels expressed in oocytes.
Biochem. Biophys. Res. Commun., 2008 Nov 21 , 376 (525-30).

211

Rusznák Z et al. Voltage-gated potassium channel (Kv) subunits expressed in the rat cochlear nucleus.
J. Histochem. Cytochem., 2008 May , 56 (443-65).

212

Pan Y et al. Functional coupling between the Kv1.1 channel and aldoketoreductase Kvbeta1.
J. Biol. Chem., 2008 Mar 28 , 283 (8634-42).

213

Lü Q et al. Disruption of Kv1.1 N-type inactivation by novel small molecule inhibitors (disinactivators).
Bioorg. Med. Chem., 2008 Mar 15 , 16 (3067-75).

214

Shook SJ et al. Novel mutation in KCNA1 causes episodic ataxia with paroxysmal dyspnea.
Muscle Nerve, 2008 Mar , 37 (399-402).

215

216

218

Nishimoto Y et al. Determination of editors at the novel A-to-I editing positions.
Neurosci. Res., 2008 Jun , 61 (201-6).

222

Salom JB et al. Role of K+ and Ca2+ fluxes in the cerebroarterial vasoactive effects of sildenafil.
Eur. J. Pharmacol., 2008 Feb 26 , 581 (138-47).

223

Jen JC Recent advances in the genetics of recurrent vertigo and vestibulopathy.
Curr. Opin. Neurol., 2008 Feb , 21 (3-7).

224

Lorincz A et al. Cell-type-dependent molecular composition of the axon initial segment.
J. Neurosci., 2008 Dec 31 , 28 (14329-40).

225

Imbrici P et al. A novel KCNA1 mutation identified in an Italian family affected by episodic ataxia type 1.
Neuroscience, 2008 Dec 2 , 157 (577-87).

228

González-Pérez V et al. Slow inactivation in Shaker K channels is delayed by intracellular tetraethylammonium.
J. Gen. Physiol., 2008 Dec , 132 (633-50).

229

235

Jen JC et al. Primary episodic ataxias: diagnosis, pathogenesis and treatment.
Brain, 2007 Oct , 130 (2484-93).

236

237

Bai X et al. Electrophysiological properties of human adipose tissue-derived stem cells.
Am. J. Physiol., Cell Physiol., 2007 Nov , 293 (C1539-50).

240

Punke MA et al. Amitriptyline is a potent blocker of human Kv1.1 and Kv7.2/7.3 channels.
Anesth. Analg., 2007 May , 104 (1256-64, tables of contents).

241

244

246

Falace A et al. Inherited neuromyotonia: a clinical and genetic study of a family.
Neuromuscul. Disord., 2007 Jan , 17 (23-7).

247

Rivera J et al. The role of Kif5B in axonal localization of Kv1 K(+) channels.
Eur. J. Neurosci., 2007 Jan , 25 (136-46).

248

Imbrici P et al. Episodic ataxia type 1 mutation F184C alters Zn2+-induced modulation of the human K+ channel Kv1.4-Kv1.1/Kvbeta1.1.
Am. J. Physiol., Cell Physiol., 2007 Feb , 292 (C778-87).

249

Glasscock E et al. Masking epilepsy by combining two epilepsy genes.
Nat. Neurosci., 2007 Dec , 10 (1554-8).

255

Rajakulendran S et al. Episodic ataxia type 1: a neuronal potassium channelopathy.
, 2007 Apr , 4 (258-66).

258

260

Mondal S et al. In silico detection of binding mode of J-superfamily conotoxin pl14a with Kv1.6 channel.
In Silico Biol. (Gedrukt), 2007 , 7 (175-86).

262

Gittelman JX et al. Kv1.1-containing channels are critical for temporal precision during spike initiation.
J. Neurophysiol., 2006 Sep , 96 (1203-14).

263

Raab-Graham KF et al. Activity- and mTOR-dependent suppression of Kv1.1 channel mRNA translation in dendrites.
Science, 2006 Oct 6 , 314 (144-8).

265

Clark E et al. Kv1.1 takes a deTOR from the axon to the dendrite.
Neuron, 2006 Nov 9 , 52 (399-401).

266

Abdel-Mottaleb Y et al. The first potassium channel toxin from the venom of the Iranian scorpion Odonthobuthus doriae.
FEBS Lett., 2006 Nov 13 , 580 (6254-8).

268

Beraud E et al. Block of neural Kv1.1 potassium channels for neuroinflammatory disease therapy.
Ann. Neurol., 2006 Nov , 60 (586-96).

269

Wu WK et al. Involvement of Kv1.1 and Nav1.5 in proliferation of gastric epithelial cells.
J. Cell. Physiol., 2006 May , 207 (437-44).

272

277

278

Yuan LL et al. Acceleration of K+ channel inactivation by MEK inhibitor U0126.
Am. J. Physiol., Cell Physiol., 2006 Jan , 290 (C165-71).

280

281

Furuzono S et al. Inherent pacemaker function of duodenal GIST.
Eur. J. Cancer, 2006 Jan , 42 (243-8).

288

289

Sankaranarayanan K et al. N type rapid inactivation in human Kv1.4 channels: functional role of a putative C-terminal helix.
Mol. Membr. Biol., 2005 Sep-Oct , 22 (389-400).

291

293

Barfield JP et al. The effects of putative K+ channel blockers on volume regulation of murine spermatozoa.
Biol. Reprod., 2005 May , 72 (1275-81).

294

Yan L et al. Stichodactyla helianthus peptide, a pharmacological tool for studying Kv3.2 channels.
Mol. Pharmacol., 2005 May , 67 (1513-21).

295

Kline DD et al. Kv1.1 deletion augments the afferent hypoxic chemosensory pathway and respiration.
J. Neurosci., 2005 Mar 30 , 25 (3389-99).

296

Srairi-Abid N et al. A new type of scorpion Na+-channel-toxin-like polypeptide active on K+ channels.
Biochem. J., 2005 Jun 1 , 388 (455-64).

298

Wang J et al. Chronic hypoxia inhibits Kv channel gene expression in rat distal pulmonary artery.
Am. J. Physiol. Lung Cell Mol. Physiol., 2005 Jun , 288 (L1049-58).

300

Jung DK et al. Age-related changes in the distribution of Kv1.1 and Kv3.1 in rat cochlear nuclei.
Neurol. Res., 2005 Jun , 27 (436-40).

304

306

Devaux JJ et al. Altered ion channels in an animal model of Charcot-Marie-Tooth disease type IA.
J. Neurosci., 2005 Feb 9 , 25 (1470-80).

307

Plane F et al. Heteromultimeric Kv1 channels contribute to myogenic control of arterial diameter.
Circ. Res., 2005 Feb 4 , 96 (216-24).

311

Herrmann A et al. [Episodic ataxias]
Tidsskr. Nor. Laegeforen., 2005 Aug 11 , 125 (2005-7).

313

Gubitosi-Klug RA et al. The human Kv1.1 channel is palmitoylated, modulating voltage sensing: Identification of a palmitoylation consensus sequence.
Proc. Natl. Acad. Sci. U.S.A., 2005 Apr 26 , 102 (5964-8).

318

Manganas LN et al. Calnexin regulates mammalian Kv1 channel trafficking.
Biochem. Biophys. Res. Commun., 2004 Sep 17 , 322 (577-84).

319

Wang W Renal potassium channels: recent developments.
Curr. Opin. Nephrol. Hypertens., 2004 Sep , 13 (549-55).

321

Jow F et al. Functional coupling of intracellular calcium and inactivation of voltage-gated Kv1.1/Kvbeta1.1 A-type K+ channels.
Proc. Natl. Acad. Sci. U.S.A., 2004 Oct 26 , 101 (15535-40).

323

Kauferstein S et al. Novel conopeptides of the I-superfamily occur in several clades of cone snails.
Toxicon, 2004 Oct , 44 (539-48).

324

Arroyo EJ et al. Acute demyelination disrupts the molecular organization of peripheral nervous system nodes.
J. Comp. Neurol., 2004 Nov 22 , 479 (424-34).

329

Serratrice J Myokimia and potassium channel gene Kv1.1.
Acta Myol, 2004 May , 23 (VI).

332

333

Ferber M et al. Identification of a mammalian target of kappaM-conotoxin RIIIK.
Toxicon, 2004 Jun 15 , 43 (915-21).

335

Vennekamp J et al. Kv1.3-blocking 5-phenylalkoxypsoralens: a new class of immunomodulators.
Mol. Pharmacol., 2004 Jun , 65 (1364-74).

336

Wang L et al. Identification of a Kv3.4 channel in corneal epithelial cells.
Invest. Ophthalmol. Vis. Sci., 2004 Jun , 45 (1796-803).

337

Zhang ZH et al. Disinactivation of N-type inactivation of voltage-gated K channels by an erbstatin analogue.
J. Biol. Chem., 2004 Jul 9 , 279 (29226-30).

339

Li H et al. Selective elimination of I(K,slow1) in mouse ventricular myocytes expressing a dominant negative Kv1.5alpha subunit.
Am. J. Physiol. Heart Circ. Physiol., 2004 Jan , 286 (H319-28).

342

Duzhyy DE et al. Cloning and developmental expression of Shaker potassium channels in the cochlea of the chicken.
Brain Res. Mol. Brain Res., 2004 Feb 5 , 121 (70-85).

343

Lu Y et al. Activity-dependent regulation of the potassium channel subunits Kv1.1 and Kv3.1.
J. Comp. Neurol., 2004 Feb 23 , 470 (93-106).

345

347

Lee H et al. A novel mutation in KCNA1 causes episodic ataxia without myokymia.
Hum. Mutat., 2004 Dec , 24 (536).

348

Harvey AL et al. Dendrotoxins: structure-activity relationships and effects on potassium ion channels.
Curr. Med. Chem., 2004 Dec , 11 (3065-72).

351

Fry M et al. Properties of Xenopus Kv1.10 channels expressed in HEK293 cells.
J. Neurobiol., 2004 Aug , 60 (227-35).

352

Escobar LI et al. A voltage-gated K(+) current in renal inner medullary collecting duct cells.
Am. J. Physiol., Cell Physiol., 2004 Apr , 286 (C965-74).

359

Grunnet M et al. The voltage-gated potassium channel subunit, Kv1.3, is expressed in epithelia.
Biochim. Biophys. Acta, 2003 Sep 22 , 1616 (85-94).

360

Albarwani S et al. Voltage-gated K+ channels in rat small cerebral arteries: molecular identity of the functional channels.
J. Physiol. (Lond.), 2003 Sep 15 , 551 (751-63).

363

Grunnet M et al. KCNE4 is an inhibitory subunit to Kv1.1 and Kv1.3 potassium channels.
Biophys. J., 2003 Sep , 85 (1525-37).

364

370

Winklhofer M et al. Analysis of phosphorylation-dependent modulation of Kv1.1 potassium channels.
Neuropharmacology, 2003 May , 44 (829-42).

371

Huys I et al. Evidence for a function-specific mutation in the neurotoxin, parabutoxin 3.
Eur. J. Neurosci., 2003 May , 17 (1786-92).

379

Zhang ZH et al. Inhibitory effects of pimozide on cloned and native voltage-gated potassium channels.
Brain Res. Mol. Brain Res., 2003 Jul 4 , 115 (29-38).

380

384

Kauferstein S et al. A novel conotoxin inhibiting vertebrate voltage-sensitive potassium channels.
Toxicon, 2003 Jul , 42 (43-52).

387

388

Zhou J et al. Regional upregulation of Kv2.1-encoded current, IK,slow2, in Kv1DN mice is abolished by crossbreeding with Kv2DN mice.
Am. J. Physiol. Heart Circ. Physiol., 2003 Feb , 284 (H491-500).

390

392

Petersson S et al. Truncation of the Shaker-like voltage-gated potassium channel, Kv1.1, causes megencephaly.
Eur. J. Neurosci., 2003 Dec , 18 (3231-40).

396

Herson PS et al. A mouse model of episodic ataxia type-1.
Nat. Neurosci., 2003 Apr , 6 (378-83).

399

Varshney A et al. Modulation of voltage sensitivity by N-terminal cytoplasmic residues in human Kv1.2 channels.
Eur. Biophys. J., 2002 Sep , 31 (365-72).

400

Matthias K et al. Modulation of voltage-gated K(+) channels Kv11 and Kv1 4 by forskolin.
Neuropharmacology, 2002 Sep , 43 (444-9).

401

Jiang B et al. Endogenous Kv channels in human embryonic kidney (HEK-293) cells.
Mol. Cell. Biochem., 2002 Sep , 238 (69-79).

404

407

408

Arroyo EJ et al. Genetic dysmyelination alters the molecular architecture of the nodal region.
J. Neurosci., 2002 Mar 1 , 22 (1726-37).

409

Shimizu Y et al. Cumulative inactivation and the pore domain in the Kv1 channels.
Pflugers Arch., 2002 Mar , 443 (720-30).

412

Glazebrook PA et al. Potassium channels Kv1.1, Kv1.2 and Kv1.6 influence excitability of rat visceral sensory neurons.
J. Physiol. (Lond.), 2002 Jun 1 , 541 (467-82).

413

Tian S et al. Regulation of the voltage-gated K+ channel KCNA10 by KCNA4B, a novel beta-subunit.
Am. J. Physiol. Renal Physiol., 2002 Jul , 283 (F142-9).

414

Rea R et al. Variable K(+) channel subunit dysfunction in inherited mutations of KCNA1.
J. Physiol. (Lond.), 2002 Jan 1 , 538 (5-23).

415

Mason DE et al. Molecular basis of voltage-dependent potassium currents in porcine granulosa cells.
Mol. Pharmacol., 2002 Jan , 61 (201-13).

417

Kerschbaum HH et al. A Shaker homologue encodes an A-type current in Xenopus laevis.
Brain Res., 2002 Feb 8 , 927 (55-68).

418

Gamper N et al. IGF-1 up-regulates K+ channels via PI3-kinase, PDK1 and SGK1.
Pflugers Arch., 2002 Feb , 443 (625-34).

421

Wickenden AD Potassium channels as anti-epileptic drug targets.
Neuropharmacology, 2002 Dec , 43 (1055-60).

422

Kurata HT et al. Amino-terminal determinants of U-type inactivation of voltage-gated K+ channels.
J. Biol. Chem., 2002 Aug 9 , 277 (29045-53).

423

Dodson PD et al. Two heteromeric Kv1 potassium channels differentially regulate action potential firing.
J. Neurosci., 2002 Aug 15 , 22 (6953-61).

424

425

McCormack K et al. Genetic analysis of the mammalian K+ channel beta subunit Kvbeta 2 (Kcnab2).
J. Biol. Chem., 2002 Apr 12 , 277 (13219-28).

426

428

Baloh RW et al. Genetics of familial episodic vertigo and ataxia.
Ann. N. Y. Acad. Sci., 2002 Apr , 956 (338-45).

429

Lerche H et al. Ion channels and epilepsy.
Am. J. Med. Genet., 2001 Summer , 106 (146-59).

430

Brunner M et al. Characterization of mice with a combined suppression of I(to) and I(K,slow).
Am. J. Physiol. Heart Circ. Physiol., 2001 Sep , 281 (H1201-9).

434

Rasband MN et al. Distinct potassium channels on pain-sensing neurons.
Proc. Natl. Acad. Sci. U.S.A., 2001 Nov 6 , 98 (13373-8).

438

Liguori R et al. Familial continuous motor unit activity and epilepsy.
Muscle Nerve, 2001 May , 24 (630-3).

442

Tytgat J et al. New polypeptide components purified from mamba venom.
FEBS Lett., 2001 Mar 2 , 491 (217-21).

444

Hinck D et al. Gallamine triethiodide selectively blocks voltage-gated potassium channels in Ranvier nodes.
Gen. Physiol. Biophys., 2001 Mar , 20 (83-95).

445

Fry M et al. Cloning and expression of three K+ channel cDNAs from Xenopus muscle.
Brain Res. Mol. Brain Res., 2001 Jun 20 , 90 (135-48).

449

450

Ekhterae D et al. Bcl-2 decreases voltage-gated K+ channel activity and enhances survival in vascular smooth muscle cells.
Am. J. Physiol., Cell Physiol., 2001 Jul , 281 (C157-65).

452

Arroyo EJ et al. Internodal specializations of myelinated axons in the central nervous system.
Cell Tissue Res., 2001 Jul , 305 (53-66).

455

Rasband MN et al. Subunit composition and novel localization of K+ channels in spinal cord.
J. Comp. Neurol., 2001 Jan 1 , 429 (166-76).

462

Kourrich S et al. Kaliotoxin, a Kv1.1 and Kv1.3 channel blocker, improves associative learning in rats.
Behav. Brain Res., 2001 Apr 8 , 120 (35-46).

464

Andrews EM et al. Voltage-gated K+ channels in chemoreceptor sensory neurons of rat petrosal ganglion.
Brain Res., 2001 Apr 6 , 897 (199-203).

465

Platoshyn O et al. Chronic hypoxia decreases K(V) channel expression and function in pulmonary artery myocytes.
Am. J. Physiol. Lung Cell Mol. Physiol., 2001 Apr , 280 (L801-12).

466

Fernandez M et al. Familial dyskinesia and facial myokymia (FDFM): a novel movement disorder.
Ann. Neurol., 2001 Apr , 49 (486-92).

468

470

Iwasa H et al. Genetic variations in five genes involved in the excitement of cardiomyocytes.
J. Hum. Genet., 2001 , 46 (549-52).

472

Manganas LN et al. Subunit composition determines Kv1 potassium channel surface expression.
J. Biol. Chem., 2000 Sep 22 , 275 (29685-93).

473

Varshney A et al. Cytoplasmic residues influence the voltage-dependence of the gating of human K+ channels.
Neuroreport, 2000 Sep 11 , 11 (2913-7).

477

Ouadid-Ahidouch H et al. KV1.1 K(+) channels identification in human breast carcinoma cells: involvement in cell proliferation.
Biochem. Biophys. Res. Commun., 2000 Nov 19 , 278 (272-7).

478

Kuryshev YA et al. KChAP as a chaperone for specific K(+) channels.
Am. J. Physiol., Cell Physiol., 2000 May , 278 (C931-41).

479

Osipenko ON et al. Potential role for kv3.1b channels as oxygen sensors.
Circ. Res., 2000 Mar 17 , 86 (534-40).

482

Lang R et al. KCNA10: a novel ion channel functionally related to both voltage-gated potassium and CNG cation channels.
Am. J. Physiol. Renal Physiol., 2000 Jun , 278 (F1013-21).

483

Klockgether T et al. The molecular biology of the autosomal-dominant cerebellar ataxias.
Mov. Disord., 2000 Jul , 15 (604-12).

484

Rolf S et al. Effects of antiarrhythmic drugs on cloned cardiac voltage-gated potassium channels expressed in Xenopus oocytes.
Naunyn Schmiedebergs Arch. Pharmacol., 2000 Jul , 362 (22-31).

485

486

Wang JY et al. Role of K(+) channel expression in polyamine-dependent intestinal epithelial cell migration.
Am. J. Physiol., Cell Physiol., 2000 Feb , 278 (C303-14).

489

Wrisch A et al. Structural differences of bacterial and mammalian K+ channels.
J. Biol. Chem., 2000 Dec 15 , 275 (39345-53).

495

496

497

Chiu SY et al. Analysis of potassium channel functions in mammalian axons by gene knockouts.
J. Neurocytol., 1999 Apr-May , 28 (349-64).

499

Pennington MW et al. Role of disulfide bonds in the structure and potassium channel blocking activity of ShK toxin.
Biochemistry, 1999 Nov 2 , 38 (14549-58).

500

Islas LD et al. Voltage sensitivity and gating charge in Shaker and Shab family potassium channels.
J. Gen. Physiol., 1999 Nov , 114 (723-42).

501

Rho JM et al. Developmental seizure susceptibility of kv1.1 potassium channel knockout mice.
Dev. Neurosci., 1999 Nov , 21 (320-7).

505

Sheikh KA et al. The distribution of ganglioside-like moieties in peripheral nerves.
Brain, 1999 Mar , 122 ( Pt 3) (449-60).

506

Galeotti N et al. Role of potassium channels in the antinociception induced by agonists of alpha2-adrenoceptors.
Br. J. Pharmacol., 1999 Mar , 126 (1214-20).

508

Zhou L et al. Determinants of excitability at transition zones in Kv1.1-deficient myelinated nerves.
J. Neurosci., 1999 Jul 15 , 19 (5768-81).

510

Boland LM et al. Protein kinase C inhibits Kv1.1 potassium channel function.
Am. J. Physiol., 1999 Jul , 277 (C100-10).

514

516

Patten CD et al. Structural and functional modularity of voltage-gated potassium channels.
FEBS Lett., 1999 Dec 17 , 463 (375-81).

518

521

Mourre C et al. Distribution in rat brain of binding sites of kaliotoxin, a blocker of Kv1.1 and Kv1.3 alpha-subunits.
J. Pharmacol. Exp. Ther., 1999 Dec , 291 (943-52).

522

Yeung SY et al. Inhibition of neuronal KV potassium currents by the antidepressant drug, fluoxetine.
Br. J. Pharmacol., 1999 Dec , 128 (1609-15).

523

Galeotti N et al. The role of potassium channels in antihistamine analgesia.
Neuropharmacology, 1999 Dec , 38 (1893-901).

527

Lee YT et al. Inhibition of hKv2.1, a major human neuronal voltage-gated K+ channel, by meclofenamic acid.
Eur. J. Pharmacol., 1999 Aug 13 , 378 (349-56).

529

Coleman SK et al. Subunit composition of Kv1 channels in human CNS.
J. Neurochem., 1999 Aug , 73 (849-58).

532

Lombardi SJ et al. Probing the potassium channel Kv beta 1/Kv1.1 interaction using a random peptide display library.
Ann. N. Y. Acad. Sci., 1999 Apr 30 , 868 (427-30).

533

535

Mathur R et al. Ile-177 and Ser-180 in the S1 segment are critically important in Kv1.1 channel function.
J. Biol. Chem., 1999 Apr 23 , 274 (11487-93).

539

Galeotti N et al. Effect of potassium channel modulators in mouse forced swimming test.
Br. J. Pharmacol., 1999 Apr , 126 (1653-9).

541

543

544

England JD et al. Abnormal distributions of potassium channels in human neuromas.
Neurosci. Lett., 1998 Oct 9 , 255 (37-40).

545

Imredy JP et al. A snake toxin inhibitor of inward rectifier potassium channel ROMK1.
Biochemistry, 1998 Oct 20 , 37 (14867-74).

550

Harvey AL et al. What can toxins tell us for drug discovery?
Toxicon, 1998 Nov , 36 (1635-40).

555

Allen ML et al. Cyclic AMP regulates potassium channel expression in C6 glioma by destabilizing Kv1.1 mRNA.
Proc. Natl. Acad. Sci. U.S.A., 1998 Jun 23 , 95 (7693-8).

557

Martínez F et al. Site directed mutants of Noxiustoxin reveal specific interactions with potassium channels.
FEBS Lett., 1998 Jun 16 , 429 (381-4).

561

Clark JD et al. Hyperalgesia in mice lacking the Kv1.1 potassium channel gene.
Neurosci. Lett., 1998 Jul 24 , 251 (121-4).

563

Shon KJ et al. kappa-Conotoxin PVIIA is a peptide inhibiting the shaker K+ channel.
J. Biol. Chem., 1998 Jan 2 , 273 (33-8).

565

Rasband MN et al. Potassium channel distribution, clustering, and function in remyelinating rat axons.
J. Neurosci., 1998 Jan 1 , 18 (36-47).

567

569

Kálmán K et al. ShK-Dap22, a potent Kv1.3-specific immunosuppressive polypeptide.
J. Biol. Chem., 1998 Dec 4 , 273 (32697-707).

570

Leicher T et al. Coexpression of the KCNA3B gene product with Kv1.5 leads to a novel A-type potassium channel.
J. Biol. Chem., 1998 Dec 25 , 273 (35095-101).

572

Blaine JT et al. Heteromultimeric potassium channels formed by members of the Kv2 subfamily.
J. Neurosci., 1998 Dec 1 , 18 (9585-93).

574

Gratacós E et al. Kv1.1 channel antisense attenuates learning and modulation of dentate polysialylated NCAM.
Neuroreport, 1998 Aug 24 , 9 (2727-31).

578

Scheffer H et al. Three novel KCNA1 mutations in episodic ataxia type I families.
Hum. Genet., 1998 Apr , 102 (464-6).

579

Höllerer-Beitz G et al. Influence of detergents on the function of cloned potassium channels.
Recept. Channels, 1998 , 5 (61-78).

580

Brandt T et al. Episodic ataxia type 1 and 2 (familial periodic ataxia/vertigo).
Audiol. Neurootol., 1997 Nov-Dec , 2 (373-83).

581

Suessbrich H et al. Specific block of cloned Herg channels by clofilium and its tertiary analog LY97241.
FEBS Lett., 1997 Sep 8 , 414 (435-8).

586

Gómez-Hernandez JM et al. Molecular basis for different pore properties of potassium channels from the rat brain Kv1 gene family.
Pflugers Arch., 1997 Nov , 434 (661-8).

589

Orias M et al. Genomic localization of the human gene for KCNA10, a cGMP-activated K channel.
Genomics, 1997 May 15 , 42 (33-7).

593

Elliott AA et al. Voltage-dependent inhibition of RCK1 K+ channels by phenol, p-cresol, and benzyl alcohol.
Mol. Pharmacol., 1997 Mar , 51 (475-83).

595

Ghelardini C et al. Effect of K+ channel modulation on mouse feeding behaviour.
Eur. J. Pharmacol., 1997 Jun 18 , 329 (1-8).

597

Verma-Kurvari S et al. Regional and cellular expression patterns of four K+ channel mRNAs in the adult rat brain.
Brain Res. Mol. Brain Res., 1997 Jun , 46 (54-62).

600

Harvey AL Recent studies on dendrotoxins and potassium ion channels.
Gen. Pharmacol., 1997 Jan , 28 (7-12).

604

Tytgat J et al. Effect of fluoxetine on a neuronal, voltage-dependent potassium channel (Kv1.1).
Br. J. Pharmacol., 1997 Dec , 122 (1417-24).

605

609

Garratt JC et al. Blockade of two voltage-dependent potassium channels, mKv1.1 and mKv1.2, by docosahexaenoic acid.
Eur. J. Pharmacol., 1996 Oct 31 , 314 (393-6).

610

Stephens GJ et al. Studies on the blocking action of human Kv3.4 inactivation peptide variants in the mouse cloned Kv1.1 K+ channel.
J. Physiol. (Lond.), 1996 Oct 1 , 496 ( Pt 1) (145-54).

614

Wang Z et al. Comparison of binding and block produced by alternatively spliced Kvbeta1 subunits.
J. Biol. Chem., 1996 Nov 8 , 271 (28311-7).

618

623

Heinemann SH et al. Functional characterization of Kv channel beta-subunits from rat brain.
J. Physiol. (Lond.), 1996 Jun 15 , 493 ( Pt 3) (625-33).

626

628

Baker MD et al. Characteristics of type I and type II K+ channels in rabbit cultured Schwann cells.
J. Physiol. (Lond.), 1996 Jan 1 , 490 ( Pt 1) (79-95).

630

631

Schultz D et al. Localization of two potassium channel beta subunit genes, KCNA1B and KCNA2B.
Genomics, 1996 Feb 1 , 31 (389-91).

635

Waldegger S et al. Inhibition of minK protein induced K+ channels in Xenopus oocytes by estrogens.
Naunyn Schmiedebergs Arch. Pharmacol., 1996 Dec , 354 (698-702).

637

Bertoli A et al. Accumulation of long-lasting inactivation in rat brain K(+)-channels.
, 1996 Aug , 110 (401-12).

645

Furukawa Y Accumulation of inactivation in a cloned transient K+ channel (AKv1.1a) of Aplysia.
J. Neurophysiol., 1995 Sep , 74 (1248-57).

646

Browne DL et al. Identification of two new KCNA1 mutations in episodic ataxia/myokymia families.
Hum. Mol. Genet., 1995 Sep , 4 (1671-2).

647

Moran O et al. Properties of the Kv1.1 rat brain potassium channels expressed in mammalian cells: temperature effects.
Biochem. Biophys. Res. Commun., 1995 Oct 24 , 215 (915-20).

648

Tytgat J et al. The alpha-dendrotoxin footprint on a mammalian potassium channel.
J. Biol. Chem., 1995 Oct 20 , 270 (24776-81).

650

653

Madeja M et al. Effects of lead on cloned voltage-operated neuronal potassium channels.
Naunyn Schmiedebergs Arch. Pharmacol., 1995 Mar , 351 (320-7).

655

Teh BT et al. Familial periodic cerebellar ataxia without myokymia maps to a 19-cM region on 19p13.
Am. J. Hum. Genet., 1995 Jun , 56 (1443-9).

666

Van de Voorde A et al. Transmembrane segments critical for potassium channel function.
Biochem. Biophys. Res. Commun., 1995 Apr 26 , 209 (1094-101).

668

675

Browne DL et al. Dinucleotide repeat polymorphisms near the KCNA6 and KCNA1 loci.
Hum. Mol. Genet., 1994 May , 3 (842).

680

Stephens GJ et al. On the mechanism of 4-aminopyridine action on the cloned mouse brain potassium channel mKv1.1.
J. Physiol. (Lond.), 1994 Jun 1 , 477 ( Pt 2) (187-96).

682

683

Ivanina T et al. Phosphorylation by protein kinase A of RCK1 K+ channels expressed in Xenopus oocytes.
Biochemistry, 1994 Jul 26 , 33 (8786-92).

689

690

Tytgat J et al. Pursuing the voltage sensor of a voltage-gated mammalian potassium channel.
J. Biol. Chem., 1993 Nov 15 , 268 (23777-9).

691

Harrison NL et al. Modulation of gating of cloned rat and human K+ channels by micromolar Zn2+.
Mol. Pharmacol., 1993 Mar , 43 (482-6).

701

Klumpp DJ et al. The potassium channel MBK1 (Kv1.1) is expressed in the mouse retina.
Cell. Mol. Neurobiol., 1991 Dec , 11 (611-22).